In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...

For women age 70 and over with a common form of breast cancer, determining “the right size” of treatment can be challenging, in part because clinicians have limited tools to guide ...

With two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind.

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not. By Pam Belluck A blood test that can help diagnose Alzheimer’s disease has received ...

Researchers are examining whether samples collected show accurately certain biomarkers which denote abnormal proteins in the brain. Volunteers in the ongoing study undergo cognitive tests, an MRI and ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...